Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers

NCT00822185 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Healthy

Interventions

DRUG: vatreptacog alfa (activated)
DRUG: vatreptacog alfa (activated)
DRUG: vatreptacog alfa (activated)
DRUG: vatreptacog alfa (activated)
DRUG: placebo
DRUG: placebo
DRUG: placebo
DRUG: placebo

Sponsor

Novo Nordisk A/S